Neuromuscular Disorders Journal Citation Rate 2026

ISSN 0960-8966 eISSN 1873-2364 Elsevier BV GB

Q3 Quartile

About Neuromuscular Disorders
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Neuromuscular Disorders (ND) is a peer-reviewed academic journal covering Cardiomyopathy and Myosin Studies and Genetic Neurodegenerative Diseases, published by Elsevier BV in GB, catalogued under ISSN 0960-8966 (e-ISSN 1873-2364). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 0.36 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$3620 USD). OpenAlex records 15,999 works and 150,197 citations, with an h-index of 138.

Neuromuscular Disorders Citation Rate 2026 — In Context

Neuromuscular Disorders has a 2025 2-Year Citation Rate (OpenAlex) of 0.36, placing it in the Q3 quartile within the Cardiomyopathy and Myosin Studies research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Neuromuscular Disorders operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Neuromuscular Disorders should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Neuromuscular Disorders against similar journals in the field, use our journal comparison tool.

Submission Tips for Neuromuscular Disorders
  • Budget $3620 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Cardiomyopathy and Myosin Studies, Genetic Neurodegenerative Diseases, Mitochondrial Function and Pathology. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Neuromuscular Disorders Compares
Citation Rate vs Field Avg
-98%
Field avg: 15.15
APC vs Field Avg
-2%
Field avg: $3687

Compared against 26 journals in the same research areas.

ISSN (Print) 0960-8966
ISSN (Online) 1873-2364
Publisher Elsevier BV
Country United Kingdom
APC / Cost $3620 USD
In-depth profile & metrics

Neuromuscular Disorders is published by Elsevier BV and based in United Kingdom. It runs on a subscription or hybrid model with an article-processing charge of USD 3620.

In our subject taxonomy, Neuromuscular Disorders is classified under Cardiomyopathy and Myosin Studies, Genetic Neurodegenerative Diseases, Mitochondrial Function and Pathology and Muscle Physiology and Disorders.

Neuromuscular Disorders is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 0.362.

Research Areas
Links
Frequently Asked Questions about Neuromuscular Disorders

Neuromuscular Disorders does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 0.362 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Neuromuscular Disorders is not an open access journal.

The Article Processing Charge (APC) for Neuromuscular Disorders is $3620 USD.

Neuromuscular Disorders is published by Elsevier BV.

Neuromuscular Disorders shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Neuromuscular Disorders is 0960-8966. Its electronic ISSN (eISSN) is 1873-2364.

Neuromuscular Disorders sits in the Q3 quartile based on its latest impact factor of 0.36, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
0.362
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 0.362 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S50004817

Get weekly updates for Cardiomyopathy and Myosin Studies journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google